Results 61 to 70 of about 204,846 (354)
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune inflammatory disease of the central nervous system (CNS), characterized by pathogenic, complement-activating autoantibodies against the main water channel in the CNS, aquaporin 4 (AQP4 ...
Barbara Uzonyi +17 more
doaj +1 more source
Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production.
Neuromyelitis optica spectrum disorders (NMOSD) constitute rare autoimmune disorders of the CNS that are primarily characterized by severe inflammation of the spinal cord and optic nerve. Approximately 75% of NMOSD patients harbour circulating pathogenic
E. Cotzomi +15 more
semanticscholar +1 more source
Clinical and autoantibody phenotypes of juvenile dermatomyositis
Juvenile dermatomyositis (JDM) is a heterogeneous autoimmune inflammatory myositis with symmetrical proximal muscle weakness and a characteristic rash. Juvenile dermatomyositis is characterized by variable presentation and phenotypes.
Iryna Yuryk +5 more
core +1 more source
Objectives Idiopathic inflammatory myopathies (IIM) are a spectrum of rare autoimmune diseases characterised clinically by muscle weakness and heterogeneous systemic organ involvement.
S. Rothwell +32 more
semanticscholar +1 more source
Participant characteristics and autoantibody status.
Participant characteristics and autoantibody status.
Helen Schuilenburg (5928) +37 more
core +1 more source
Autoantibodies have been associated with autoimmune diseases. However, studies have identified autoantibodies in healthy donors (HD) who do not develop autoimmune disorders.
O. Cabral-Marques +35 more
semanticscholar +1 more source
Distinct autoantibody profiles across checkpoint inhibitor types and toxicities [PDF]
Immune checkpoint inhibitors (ICI) are increasingly used in combination. To understand the effects of different ICI categories, we characterized changes in circulating autoantibodies in patients enrolled in the E4412 trial (NCT01896999) of brentuximab ...
Yang Xie +32 more
core +1 more source
Genome-Wide Assessment of Differential DNA Methylation Associated with Autoantibody Production in Systemic Lupus Erythematosus. [PDF]
Systemic lupus erythematosus (SLE) is characterized by the development of autoantibodies associated with specific clinical manifestations. Previous studies have shown an association between differential DNA methylation and SLE susceptibility, but have ...
Sharon A Chung +6 more
doaj +1 more source
Low T-cell reactivity to TDP-43 peptides in ALS
BackgroundDysregulation of the immune system in amyotrophic lateral sclerosis (ALS) includes changes in T-cells composition and infiltration of T cells in the brain and spinal cord.
Swetha Ramachandran +10 more
doaj +1 more source
Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors
Ipilimumab induced autoantibodies in a fifth of melanoma patients. Patients who developed autoantibodies, especially thyroid autoantibodies, experienced more irAEs and had a survival and response benefit, suggesting that breaking of B-cell tolerance ...
E. D. de Moel +9 more
semanticscholar +1 more source

